NPY, neuropeptide Y, 4852

N. diseases: 381; N. variants: 12
Disease: Epileptic Seizures ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Biomarker phenotype BEFREE The reduction of the levels of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 caused by leptin, ghrelin, and NPY shows that these peptides may have anti-inflammatory effects in epileptic seizures. 27522536 2017
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Therapeutic phenotype CTD_human Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. 18005069 2007
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Biomarker phenotype CTD_human Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y. 18005069 2007
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Biomarker phenotype CTD_human Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. 16194568 2005
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Therapeutic phenotype CTD_human Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil. 16194568 2005
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Therapeutic phenotype CTD_human Seizure susceptibility of neuropeptide-Y null mutant mice in amygdala kindling and chemical-induced seizure models. 15451008 2004
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures 		0.310 Biomarker phenotype CTD_human Seizure susceptibility of neuropeptide-Y null mutant mice in amygdala kindling and chemical-induced seizure models. 15451008 2004